Predictive role of C677T MTHFR polymorphism in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration

Author： Parmeggiani Francesco Gemmati Donato Costagliola Ciro Sebastiani Adolfo Incorvaia Carlo

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.10, Iss.1, 2009-01, pp. : 81-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

An update on photodynamic therapy in age-related macular degeneration

By Rechtman Ehud Ciulla Thomas A Criswell Mark H Pollack Ayala Harris Alon

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 931-938

Informa Healthcare

Access to resources Recommend Favorite

An update on the pharmacotherapy of neovascular age-related macular degeneration

By Freund K Bailey Mrejen Sarah Gallego-Pinazo Roberto

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 8, 2013-06 ,pp. : 1017-1028

Informa Healthcare

Access to resources Recommend Favorite

Neovascular Age-Related Macular Degeneration: Potential Therapies

By Chappelow Aimee V. Kaiser Peter K.

Drugs, Vol. 68, Iss. 8, 2008-01 ,pp. : 1029-1036

Adis International

Access to resources Recommend Favorite

Pharmacogenetic labyrinth of neovascular age-related macular degeneration therapy: how to escape and move forward?

By Lazzeri Stefano Nardi Marco Bocci Guido

Pharmacogenomics, Vol. 14, Iss. 11, 2013-08 ,pp. : 1239-1242

Future Medicine

Access to resources Recommend Favorite

Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration

By Ohr Matthew Kaiser Peter K

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 4, 2012-03 ,pp. : 585-591

Informa Healthcare

Access to resources Recommend Favorite